Literature DB >> 23978910

Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.

Vijaya B Joshi1, Sean M Geary1, Aliasger K Salem1.   

Abstract

There is a need for both new and improved vaccination formulations for a range of diseases for which current vaccines are either inadequate or non-existent. Biodegradable polymer-based vaccines fulfill many of the desired properties in achieving effective long-term protection in a manner that is safe, economical, and potentially more practicable on a global scale. Here we discuss some of the work performed with micro/nanoparticles made from either synthetic (poly[lactic-co-glycolic acid] [PLGA] and polyanhydrides) or natural (chitosan) biodegradable polymers. Our attention is focused on, but not limited to, the generation of antitumor immunity where we stress the importance of particle size and co-delivery of antigen and adjuvant.

Entities:  

Keywords:  PLGA; adjuvant; biodegradable polymer; cancer vaccine; chitosan; polyanhydride

Mesh:

Substances:

Year:  2013        PMID: 23978910      PMCID: PMC4162053          DOI: 10.4161/hv.26136

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  76 in total

1.  Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.

Authors:  Wen Fan; Wei Yan; Zushun Xu; Hong Ni
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-02       Impact factor: 5.268

2.  Norovirus vaccine against experimental human Norwalk Virus illness.

Authors:  Robert L Atmar; David I Bernstein; Clayton D Harro; Mohamed S Al-Ibrahim; Wilbur H Chen; Jennifer Ferreira; Mary K Estes; David Y Graham; Antone R Opekun; Charles Richardson; Paul M Mendelman
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

3.  Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.

Authors:  Caitlin D Lemke; Jessica B Graham; Sean M Geary; Gideon Zamba; David M Lubaroff; Aliasger K Salem
Journal:  Mol Pharm       Date:  2011-08-09       Impact factor: 4.939

4.  Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.

Authors:  N Saint-Lu; S Tourdot; A Razafindratsita; L Mascarell; N Berjont; H Chabre; A Louise; L Van Overtvelt; P Moingeon
Journal:  Allergy       Date:  2009-02-12       Impact factor: 13.146

5.  Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.

Authors:  Senja K Lopac; Maria P Torres; Jennifer H Wilson-Welder; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

6.  Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.

Authors:  Janjira Intra; Aliasger K Salem
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

7.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.

Authors:  Stacey L Demento; Stephanie C Eisenbarth; Harald G Foellmer; Craig Platt; Michael J Caplan; W Mark Saltzman; Ira Mellman; Michel Ledizet; Erol Fikrig; Richard A Flavell; Tarek M Fahmy
Journal:  Vaccine       Date:  2009-04-03       Impact factor: 3.641

8.  Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model.

Authors:  Donna A Santillan; Karishma K Rai; Mark K Santillan; Yogita Krishnamachari; Aliasger K Salem; Stephen K Hunter
Journal:  Am J Obstet Gynecol       Date:  2011-06-15       Impact factor: 10.693

9.  PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.

Authors:  Chantal Keijzer; Bram Slütter; Ruurd van der Zee; Wim Jiskoot; Willem van Eden; Femke Broere
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

10.  Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN.

Authors:  S M Geary; C D Lemke; D M Lubaroff; A K Salem
Journal:  Cancer Immunol Immunother       Date:  2011-05-28       Impact factor: 6.630

View more
  23 in total

1.  Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.

Authors:  Naihan Chen; Monica M Johnson; Michael A Collier; Matthew D Gallovic; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2018-02-02       Impact factor: 9.776

2.  Nanoparticles in vaccine delivery.

Authors:  Aliasger K Salem
Journal:  AAPS J       Date:  2015-01-23       Impact factor: 4.009

3.  A single dose polyanhydride-based nanovaccine against paratuberculosis infection.

Authors:  Akanksha Thukral; Kathleen Ross; Chungyi Hansen; Yashdeep Phanse; Balaji Narasimhan; Howard Steinberg; Adel M Talaat
Journal:  NPJ Vaccines       Date:  2020-02-14       Impact factor: 7.344

4.  Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

Authors:  Bala V K Karuturi; Shailendra B Tallapaka; Pravin Yeapuri; Stephen M Curran; Sam D Sanderson; Joseph A Vetro
Journal:  Mol Pharm       Date:  2017-04-03       Impact factor: 4.939

5.  Vaccine immunotherapy for prostate cancer: from mice to men.

Authors:  David M Lubaroff; Daniel Vaena; James A Brown; Pamela Zehr; Karen C Griffith; Erica Brown; Julie Eastman; Kenneth Nepple; Ambika Kattula; Richard D Williams
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.

Authors:  Emad I Wafa; Sean M Geary; Jonathan T Goodman; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2017-01-04       Impact factor: 8.947

Review 7.  Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems.

Authors:  Xueting Wang; Ning Wang; Ning Li; Yuanyuan Zhen; Ting Wang
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

8.  Real-Time Imaging of Vaccine Biodistribution Using Zwitterionic NIR Nanoparticles.

Authors:  Wataru Katagiri; Jeong Heong Lee; Marc-André Tétrault; Homan Kang; Sinyoung Jeong; Conor L Evans; Shinya Yokomizo; Sheena Santos; Catherine Jones; Shuang Hu; Georges El Fakhri; Kosuke Tsukada; Hak Soo Choi; Satoshi Kashiwagi
Journal:  Adv Healthc Mater       Date:  2019-06-05       Impact factor: 9.933

9.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

10.  Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.

Authors:  Kawther K Ahmed; Sean M Geary; Aliasger K Salem
Journal:  J Pharm Sci       Date:  2016-01-30       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.